company background image
SXTC logo

China SXT Pharmaceuticals NasdaqCM:SXTC Stock Report

Last Price

US$0.39

Market Cap

US$1.4m

7D

14.3%

1Y

-80.6%

Updated

24 Dec, 2024

Data

Company Financials

China SXT Pharmaceuticals, Inc.

NasdaqCM:SXTC Stock Report

Market Cap: US$1.4m

SXTC Stock Overview

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. More details

SXTC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

China SXT Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for China SXT Pharmaceuticals
Historical stock prices
Current Share PriceUS$0.39
52 Week HighUS$6.39
52 Week LowUS$0.30
Beta1.12
1 Month Change1.83%
3 Month Change-35.33%
1 Year Change-80.60%
3 Year Change-99.86%
5 Year Change-99.98%
Change since IPO-100.00%

Recent News & Updates

Recent updates

China SXT Pharmaceuticals'(NASDAQ:SXTC) Share Price Is Down 12% Over The Past Year.

Feb 09
China SXT Pharmaceuticals'(NASDAQ:SXTC) Share Price Is Down 12% Over The Past Year.

Shareholder Returns

SXTCUS PharmaceuticalsUS Market
7D14.3%1.6%-2.2%
1Y-80.6%9.7%23.9%

Return vs Industry: SXTC underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.

Return vs Market: SXTC underperformed the US Market which returned 23.9% over the past year.

Price Volatility

Is SXTC's price volatile compared to industry and market?
SXTC volatility
SXTC Average Weekly Movement16.3%
Pharmaceuticals Industry Average Movement10.4%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: SXTC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: SXTC's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
200575Albert Zhouwww.sxtchina.com

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands.

China SXT Pharmaceuticals, Inc. Fundamentals Summary

How do China SXT Pharmaceuticals's earnings and revenue compare to its market cap?
SXTC fundamental statistics
Market capUS$1.36m
Earnings (TTM)-US$3.10m
Revenue (TTM)US$1.93m

0.7x

P/S Ratio

-0.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SXTC income statement (TTM)
RevenueUS$1.93m
Cost of RevenueUS$1.37m
Gross ProfitUS$553.97k
Other ExpensesUS$3.65m
Earnings-US$3.10m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.89
Gross Margin28.73%
Net Profit Margin-160.67%
Debt/Equity Ratio24.8%

How did SXTC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 03:07
End of Day Share Price 2024/12/24 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China SXT Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution